ESCMID Pipeline Corner
ESCMID offers small innovative pharmaceutical companies with early-stage antimicrobial therapies in development a platform at ECCMID to present their products to a wider audience.
ECCMID 2018 in Madrid will offer small innovative companies a platform to give an overview of their R&D pipelines and present recent advances in their early-stage products.
Contact Ursula Theuretzbacher for more information.
Monday, 23 April 2018
12:30 – 14:30, Hall Y
12:30 – 13:30 Pipeline talks
13:30 – 14:00 Research, partnerships, funding
14:00 – 14:30 Discussion, networking
ePosters are accessible via the congress app and posters can be viewed in the Pipeline Corner.
Presenting companies 2018
ECCMID Pipeline Corner moderator: Ursula Theuretzbacher, Vienna, Austria
- Antabio; Labège, France
- VenatoRx Pharmaceuticals; Malvern PA, United States
- Bugworks Research; Bangalore, India
- Forge Therapeutics; San Diego CA, United States
- Polyphor; Allschwil, Switzerland
- Cube Dx; St. Valentin, Austria
- Global Antibiotic Research & Development Partnership (GARDP)
- European Investment Bank's Infectious Disease Finance Facility
- Pew Trust's SPARK platform
Presenting companies at ECCMID 2017
• AiCuris GmbH, Germany (ePoster only)
• Allecra Therapeutics GmbH, Germany
• Arsanis Biosciences, Austria/United States
• Cantab Anti-infectives Ltd, United Kingdom
• Centauri Therapeutics Ltd, United Kingdom (ePoster only)
• Naicons Srl., Italy
• NovaBiotics Ltd, United Kingdom
• Phico Therapeutics Ltd, United Kingdom
• Scynexis Inc., United States (ePoster only)
• Septeos, France (ePoster only)
• Synthetic Biologics Inc., United States
• TAXIS Pharmaceuticals Inc., United States
Pipeline talks at ECCMID 2016 in Amsterdam
After successful initiation of the Pipeline Corner and the Pipeline Talks at ECCMID 2015 in Copenhagen, the ECCMID Programme Committee extend the new format at ECCMID 2016 in Amsterdam.
The dedicated session took place at ECCMID 2016 in Amsterdam on Sunday, 10 April 2016, 13:00 - 14:00
Presenting companies:
- BioVersys, Switzerland
- Melinta, United States
- Deutsches Zentrum für Infektionsforschung, Germany
- Discuva, United Kingdom
- Cidara, United States
- Spero, United States
- ABAC Therapeutics, Spain
- Biovertis, Germany
- Nabriva, Austria
- Vitas Pharma, India
Pipeline Corner at ECCMID 2015
The dedicated Pipeline Corner at ECCMID 2015 generated great interest among the research community, larger pharmaceutical companies, service providers, venture capital firms, and the press. The display of electronic posters has proved to be the starting point for promising discussions and meetings throughout the conference.
The posters can be found in our eLibrary under this link.
This list displays European or international initiatives active in combatting antimicrobial resistance by developing new compounds. If you would like to add a new European or international initiative or amend an existing entry, please contact the ESCMID Office.
Driving reinvestment in R&D for antibiotics and advocating their responsible use
CDC Antibiotic Resistance Solutions Initiative
Joint Programme Initiative on Antimicrobial Resistance
